CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,336 | -14.1% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $17,856 | -10.3% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $19,896 | -10.9% | 1,200 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $22,320 | +48.8% | 1,200 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $15,000 | +87.5% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $8,000 | -20.0% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $10,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |